Essa Pharma
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$8.93M
-0.4
-0.69
35
ESSA Pharma, Inc. is a clinical stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia and currently employs 35 full-time employees. The firm is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.
ESSA Pharma, Inc. is a clinical stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia and currently employs 35 full-time employees. The firm is undergoing a comprehensive review process to review its strategic options to maximize shareholder value.
Recently from Cashu
Essa Pharma Merges with XenoTherapeutics to Enhance Prostate Cancer Treatment Innovations
Essa Pharma Joins Forces with XenoTherapeutics: A New Chapter in Prostate Cancer Treatment Essa Pharma Inc., a pharmaceutical company renowned for its innovative therapies targeting prostate cancer, h…
Essa Pharma Acquired by XenoTherapeutics to Advance Prostate Cancer Treatment Innovations
Essa Pharma Completes Acquisition by XenoTherapeutics, Paving New Path in Prostate Cancer Treatment Essa Pharma Inc., a pharmaceutical company focused on developing innovative therapies for prostate c…
Essa Pharma's Acquisition by XenoTherapeutics Transforms Prostate Cancer Treatment Landscape
Essa Pharma's Strategic Acquisition Marks a New Era in Prostate Cancer Treatment Essa Pharma Inc. is on the verge of a significant transition following the overwhelming approval from its Securityholde…
Essa Pharma's Acquisition by XenoTherapeutics: A Leap Forward in Prostate Cancer Treatment
Essa Pharma's Transformative Acquisition: A New Era in Prostate Cancer Treatment Essa Pharma Inc. (NASDAQ: EPIX) is on the verge of a significant transformation following the overwhelming approval of…